Would you want to take Lyrica (pregabalin) or Neurontin (gabapentin) for pain relief after a major surgery? Both drugs belong to a class of nerve medication called gabapentinoids that are increasingly being prescribed to patients perioperatively (after surgery) as an alternative to opioid medication. The shift towards multimodal pain regimens, including gabapentin, has taken place without attention to ensuring that they, like opioids, are appropriately discontinued soon after surgery. The prevalence of prolonged use of post-operative gabapentin among older adults is unknown, as are the factors associated with prolonged use. Perioperative gabapentin, 1200 mg, administered preoperatively plus 600 mg every 8 hours continued for 72 hours after surgery did not affect time to pain cessation, the rate of pain resolution, or the proportion of patients with chronic pain at 6 months or 1 year following surgery. This review evaluated the efficacy and tolerability of peri-operative gabapentin administration to control acute post-operative pain. Peri-operative gabapentin administration was found to be effective in reducing pain scores, opioid requirements and opioid-related adverse effects in the first 24 hours after surgery. Given the significant differences between the studies and the possibility of pain assessment in cats and dogs, as well as an initial therapy plan with guidance on reassessing and adjusting the plan as needed. As such, these guidelines discuss pain management as a therapeutic con-tinuum consisting of assessment, treatment, reassessment, and plan revision. Pain management has been recognized as an essential compo- In addition, because pain intensity may be an unmeasured confounder of the association between gabapentin use and delirium, we examined how the RR estimate would change under various scenarios: (1) the prevalence difference in severe pain between gabapentin users and nonusers and (2) the relative risk between severe pain and delirium from the The purpose of this review is to critically appraise the evidence for the use of gabapentinoids for acute pain management and its impact on the development of chronic pain after surgery. Recent findings: Recent meta-analyses have revealed that prior data likely have overestimated the beneficial effects of gabapentinoids in acute perioperative Gabapentin and the related, more potent compound pregabalin have been shown to be beneficial in the treatment of neuropathic pain as well as postoperative pain following spinal surgery and hysterectomy. Gabapentin appears safe and well tolerated when used for persistent post-operative and post-traumatic pain in thoracic surgery patients, although minor side effects do occur. Gabapentin may relieve refractory chest wall pain in some of these patients, particularly those with more severe pain. some outcomes indirectness. Firm evidence for use of gabapentin is lacking as clinically relevant beneficial effect of gabapentin may be absent and harm is imminent, especially when added to multi-modal analgesia. Editorial Comment In this trustworthy systematic review, use of gabapentin for post-operative pain management was scrutinized. 300 mg on day 1, 600 mg on day 2, and 900 mg from day 3 to day 30 after surgery: Acute post-operative pain intensity in gabapentin group was significantly lower than the placebo group p<0.05). The rate of PLP at the last follow-up was lower in the gabapentin group (43.48%) compared to placebo (77.27%, p=0.033). Hah et al., 2018 25 6, 12, 24, 48, and 72 h after surgery measured by any quanti-tative pain scale.58 Secondary outcomes were postoperative subacute pain (defined as pain intensity during postopera-tive weeks 4 to 12); incidence of postoperative chronic pain (defined as pain lasting for 3 months or more); cumulative In 2006, Sihoe et al. evaluated gabapentin in the treatment of chronic pain after chest surgery (6). Twelve patients were chest trauma victims, 22 were status post video assisted thoracoscopic surgery (VATS), 8 had undergone open thoracotomies, and 3 had median sternotomies. Patients were started on a dose of gabapentin 300 mg daily Gabapentin, an anticonvulsant, has recently been suggested as an effective postoperative ‘analgesic’ agent. The objective of the present study was to examine the analgesic effectiveness, opioid-sparing effects and side effects associated with the use of gabapentin in a perioperative setting. Gabapentin 250 mg is statistically superior to placebo in the treatment of established acute postoperative pain, but the NNT of 11 for at least 50% pain relief over 6 hours with gabapentin 250 mg is of limited clinical value and inferior to commonly used analgesics. The aim was to document beneficial and harmful effects of perioperative gabapentin treatment. Methods: Randomized clinical trials comparing gabapentin vs. placebo or active placebo in adult surgical patients receiving gabapentin perioperatively were included. This review was conducted using Cochrane standards, trial sequential analysis (TSA Gabapentin and other anticonvulsant medications have been established as an effective treatment for chronic neuropathic pain and are commonly used for such conditions as herpetic neuralgia, diabetic neuropathy, and phantom limb pain following amputation. In summary, the administration of gabapentin was effective in decreasing postoperative narcotic consumption and the incidence of pruritus. There was a high risk of selection bias and a higher heterogeneity of knee flexion range in this analysis. Perioperative use of gabapentin has a significant 24-hour opioid sparing effect and improves pain score for both abdominal hysterectomy and spinal surgery. Nausea may be reduced in abdominal hysterectomy.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | |
![]() | ![]() |
![]() | ![]() |